Market Closed -
Sao Paulo
04:06:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
7.07
BRL
|
-9.71%
|
|
-13.46%
|
+19.22%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
646.7
|
213
|
207
|
300.1
|
Enterprise Value (EV)
1 |
793.5
|
435
|
432.6
|
539.8
|
P/E ratio
|
5,259
x
|
108
x
|
18.2
x
|
14
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.64
x
|
0.19
x
|
0.14
x
|
0.17
x
|
EV / Revenue
|
0.79
x
|
0.38
x
|
0.29
x
|
0.31
x
|
EV / EBITDA
|
27.7
x
|
18.3
x
|
6.82
x
|
6.61
x
|
EV / FCF
|
-29.3
x
|
7.15
x
|
11.4
x
|
11.8
x
|
FCF Yield
|
-3.41%
|
14%
|
8.75%
|
8.47%
|
Price to Book
|
0.77
x
|
0.25
x
|
0.24
x
|
0.34
x
|
Nbr of stocks (in thousands)
|
50,603
|
50,603
|
50,603
|
50,603
|
Reference price
2 |
12.78
|
4.210
|
4.090
|
5.930
|
Announcement Date
|
3/16/21
|
3/16/22
|
3/15/23
|
3/7/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,161
|
1,132
|
1,004
|
1,141
|
1,483
|
1,749
|
EBITDA
1 |
32.3
|
35.37
|
28.65
|
23.82
|
63.42
|
81.68
|
EBIT
1 |
11.4
|
13.13
|
6.647
|
-2.112
|
35.63
|
51.32
|
Operating Margin
|
0.98%
|
1.16%
|
0.66%
|
-0.19%
|
2.4%
|
2.93%
|
Earnings before Tax (EBT)
1 |
-10.32
|
4.175
|
-17.78
|
-19.19
|
12.78
|
26.27
|
Net income
1 |
2.681
|
-7.487
|
0.123
|
1.979
|
11.36
|
21.36
|
Net margin
|
0.23%
|
-0.66%
|
0.01%
|
0.17%
|
0.77%
|
1.22%
|
EPS
2 |
0.1000
|
-0.2771
|
0.002430
|
0.0391
|
0.2244
|
0.4221
|
Free Cash Flow
1 |
13.2
|
-39
|
-27.07
|
60.86
|
37.83
|
45.74
|
FCF margin
|
1.14%
|
-3.44%
|
-2.7%
|
5.33%
|
2.55%
|
2.62%
|
FCF Conversion (EBITDA)
|
40.87%
|
-
|
-
|
255.53%
|
59.65%
|
56%
|
FCF Conversion (Net income)
|
492.32%
|
-
|
-
|
3,075.23%
|
333.16%
|
214.11%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/16/20
|
7/16/20
|
3/16/21
|
3/16/22
|
3/15/23
|
3/7/24
|
Fiscal Period: December |
2022 Q2
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
12.27
|
Net margin
|
-
|
EPS
2 |
0.2420
|
Dividend per Share
|
-
|
Announcement Date
|
8/10/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
132
|
329
|
147
|
222
|
226
|
240
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.084
x
|
9.316
x
|
5.126
x
|
9.318
x
|
3.557
x
|
2.935
x
|
Free Cash Flow
1 |
13.2
|
-39
|
-27.1
|
60.9
|
37.8
|
45.7
|
ROE (net income / shareholders' equity)
|
0.72%
|
-1.56%
|
0.02%
|
0.24%
|
1.35%
|
2.48%
|
ROA (Net income/ Total Assets)
|
0.7%
|
0.78%
|
0.33%
|
-0.09%
|
1.51%
|
2.12%
|
Assets
1 |
380.4
|
-962.8
|
37.76
|
-2,194
|
749.9
|
1,005
|
Book Value Per Share
2 |
18.20
|
17.20
|
16.50
|
16.60
|
16.80
|
17.20
|
Cash Flow per Share
2 |
2.130
|
1.820
|
4.080
|
1.900
|
1.120
|
0.8700
|
Capex
1 |
11.9
|
14.3
|
27.7
|
48.9
|
34.3
|
49.5
|
Capex / Sales
|
1.03%
|
1.26%
|
2.76%
|
4.29%
|
2.31%
|
2.83%
|
Announcement Date
|
7/16/20
|
7/16/20
|
3/16/21
|
3/16/22
|
3/15/23
|
3/7/24
|
|
1st Jan change
|
Capi.
|
---|
| +19.22% | 69.8M | | -32.21% | 15.27B | | -31.97% | 10.84B | | -30.42% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -1.17% | 4.71B | | +52.19% | 4.29B | | -14.86% | 3.33B | | -6.93% | 3.01B |
Other Drug Retailers
|